FDA approves Eisai's thyroid cancer drug

February 13, 2015 3:11 PM

6 0

FDA approves Eisai's thyroid cancer drug

(Reuters) - The U.S. Food and Drug Administration said it approved Japan's Eisai Co Ltd's drug to treat the most common form of thyroid cancer more than two months ahead of the review date.

The drug, Lenvima, was cleared for use in patients with progressive, differentiated thyroid cancer (DTC) who have not adequately responded to radioactive iodine therapy, the agency said on Thursday. (1.usa.gov/1vIeI1Q)

Also read: Trump establishes task forces to eliminate ‘job killing regulations’

Read more

To category page